Page last updated: 2024-08-22

glucosamine and Epilepsy Progressive Myoclonic 2

glucosamine has been researched along with Epilepsy Progressive Myoclonic 2 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Allenger, EJ; Armstrong, DD; Brainson, CF; Brewer, MK; Bruntz, RC; Chikwana, VM; Clarke, HA; Conroy, LR; Contreras, CJ; DePaoli-Roach, AA; Drake, RR; Emanuelle, S; Gentry, MS; Hawkinson, TR; Hurley, TD; Johnson, LA; Macedo, JKA; Mahalingan, KK; Markussen, KH; Mestas, A; Roach, PJ; Rondon, AL; Sanders, WC; Segvich, DM; Shaffer, R; Stanback, AE; Sun, RC; Tang, B; Taylor, RE; Vander Kooi, CW; Waechter, CJ; Young, LEA; Zhou, Z1

Other Studies

1 other study(ies) available for glucosamine and Epilepsy Progressive Myoclonic 2

ArticleYear
Brain glycogen serves as a critical glucosamine cache required for protein glycosylation.
    Cell metabolism, 2021, 07-06, Volume: 33, Issue:7

    Topics: Animals; Brain; Cells, Cultured; Disease Models, Animal; Female; Glucosamine; Glycogen; Glycogen Synthase; Glycogenolysis; Glycosylation; Lafora Disease; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Processing, Post-Translational

2021